Cardiovascular manifestations in idiopathic inflammatory myopathies
暂无分享,去创建一个
S. Shinjo | Meera Shah | Jessica Day | L. Gupta | J. Day
[1] T. Iwaniec,et al. Thrombin generation potential is increased in patients with autoimmune inflammatory myopathies. , 2022, Advances in medical sciences.
[2] R. J. van der Geest,et al. Using multi-parametric quantitative MRI to screen for cardiac involvement in patients with idiopathic inflammatory myopathy , 2022, Scientific Reports.
[3] H. Mann,et al. Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study , 2022, Frontiers in Medicine.
[4] C. Kavadichanda,et al. COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis , 2022, Seminars in Arthritis and Rheumatism.
[5] J. Lei,et al. Thromboembolic events in idiopathic inflammatory myopathy: a retrospective study in China , 2022, Clinical Rheumatology.
[6] D. Andersson,et al. Myositis-Specific Autoantibodies and QTc Changes by ECG in Idiopathic Inflammatory Myopathies. , 2022, Rheumatology.
[7] E. Taraldsrud,et al. Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis—a cross-sectional study , 2022, Rheumatology International.
[8] E. Lai,et al. Premature coronary artery disease in patients with immune-mediated inflammatory disease: a population-based study , 2022, RMD Open.
[9] Wei Chen,et al. Relative basal myocardial weakness: differentiating dermatomyositis and polymyositis with cardiac involvement from viral myocarditis using speckle-tracking echocardiography and quantification of myocardial work. , 2021, Quantitative imaging in medicine and surgery.
[10] L. Qin,et al. Coronary Heart Disease and Cardiovascular Risk Factors in Patients With Idiopathic Inflammatory Myopathies: A Systemic Review and Meta-Analysis , 2022, Frontiers in Medicine.
[11] T. Mimori,et al. ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis , 2022, Frontiers in Immunology.
[12] L. Qin,et al. Left ventricle diastolic dysfunction in idiopathic inflammatory myopathies: A meta-analysis and systematic review. , 2021, Modern rheumatology.
[13] I. Wicks,et al. Defining cardiac involvement in idiopathic inflammatory myopathies: a systematic review. , 2021, Rheumatology.
[14] Qing-jun Wu,et al. Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry , 2021, Clinical Rheumatology.
[15] Hung-An Chen,et al. Time‐Dependent Analysis of Risk of New‐Onset Heart Failure Among Patients With Polymyositis and Dermatomyositis , 2021, Arthritis & rheumatology.
[16] M. Needham,et al. Idiopathic inflammatory myopathies: a review , 2021, Internal medicine journal.
[17] Geetika Arora,et al. Arrhythmia prevalence among patients with Polymyositis-Dermatomyositis in the United States: an observational study. , 2021, Heart rhythm.
[18] A. Mammen,et al. Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis , 2021, Clinical Rheumatology.
[19] K. Rossing,et al. Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy , 2021, Oxford medical case reports.
[20] M. Holmqvist,et al. Evaluation of risk factors and biomarkers related to arterial and venous thrombotic events in idiopathic inflammatory myopathies , 2021, Scandinavian journal of rheumatology.
[21] Jiayu Sun,et al. Phenotyping of myocardial involvement by cardiac magnetic resonance in idiopathic inflammatory myopathies , 2021, European Radiology.
[22] J. Lei,et al. Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody. , 2020, Seminars in arthritis and rheumatism.
[23] OUP accepted manuscript , 2021, Rheumatology.
[24] OUP accepted manuscript , 2021, Rheumatology.
[25] Q. Fang,et al. Ventricular arrhythmia predicts poor outcome in polymyositis/dermatomyositis with myocardial involvement. , 2020, Rheumatology.
[26] F. Ng,et al. Pro-arrhythmic electrophysiological and structural remodelling in rheumatoid arthritis. , 2020, American journal of physiology. Heart and circulatory physiology.
[27] M. Beer,et al. Myocardial involvement and deformation abnormalities in idiopathic inflammatory myopathy assessed by CMR feature tracking , 2020, The International Journal of Cardiovascular Imaging.
[28] Xiaoyue Zhou,et al. CMR T1 mapping and strain analysis in idiopathic inflammatory myopathy: evaluation in patients with negative late gadolinium enhancement and preserved ejection fraction , 2020, European Radiology.
[29] S. Reddy,et al. High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies. , 2020, Rheumatology.
[30] M. Milone,et al. Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy. , 2020, Mayo Clinic proceedings.
[31] D. Benaiges,et al. Atherosclerosis and inflammation. New therapeutic approaches. , 2020, Medicina clinica.
[32] F. Ibrahim,et al. Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis , 2020, Clinical Rheumatology.
[33] Q. Wang,et al. Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies. , 2020, Cardiovascular diagnosis and therapy.
[34] K. Kim,et al. Incidence, survival, and risk of cardiovascular events in adult inflammatory myopathies in South Korea: a nationwide population-based study , 2020, Scandinavian journal of rheumatology.
[35] Jie Wang,et al. Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy , 2020, Journal of Cardiovascular Magnetic Resonance.
[36] E. Roach,et al. Juvenile Dermatomyositis and the Inflammatory Myopathies , 2020, Seminars in Neurology.
[37] W. Rottbauer,et al. Sporadic inclusion body myositis: no specific cardiac involvement in cardiac magnetic resonance tomography , 2020, Journal of Neurology.
[38] Shuyang Zhang,et al. Clinical Characteristics, Treatment, and Outcomes in Patients with Idiopathic Inflammatory Myopathy Concomitant with Heart Failure. , 2020, International heart journal.
[39] Y. Kao Yang,et al. Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan. , 2019, Rheumatology.
[40] P. Sanders,et al. Cardiac involvement in idiopathic inflammatory myopathies detected by cardiac magnetic resonance imaging , 2019, Clinical Rheumatology.
[41] I. Sjaastad,et al. Association Between Nailfold Capillary Density and Pulmonary and Cardiac Involvement in Medium to Longstanding Juvenile Dermatomyositis , 2019, Arthritis care & research.
[42] I. Lundberg,et al. Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study , 2019, The Journal of Rheumatology.
[43] I. Lundberg,et al. Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset , 2018, Arthritis care & research.
[44] K. Rayner,et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. , 2018, Atherosclerosis.
[45] J. Silverberg,et al. Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample , 2018, Rheumatology.
[46] J. Sergeant,et al. Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies , 2018, Rheumatology.
[47] A. Huber,et al. Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping , 2018, Journal of Cardiovascular Magnetic Resonance.
[48] J. Albayda,et al. Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement. , 2018, Seminars in arthritis and rheumatism.
[49] J. Lamb,et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research , 2017, Annals of the rheumatic diseases.
[50] G. C. Dobloug,et al. Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study , 2017, Annals of the rheumatic diseases.
[51] Hong Tang,et al. Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study , 2017, The International Journal of Cardiovascular Imaging.
[52] Y. Lee,et al. Idiopathic inflammatory myopathy and the risk of venous thromboembolism: a meta-analysis , 2017, Rheumatology International.
[53] A. Capucci,et al. Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study , 2017, The Journal of Rheumatology.
[54] I. Sjaastad,et al. Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies , 2016, RMD Open.
[55] S. Kay,et al. Cardiac Abnormalities in Adult Patients With Polymyositis or Dermatomyositis as Assessed by Noninvasive Modalities , 2016, Arthritis care & research.
[56] H. Abenhaim,et al. Risk of Venous Thromboembolic Events in Pregnant Patients With Autoimmune Diseases , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[57] R. Miossi,et al. Electrocardiographic changes in dermatomyositis and polymyositis. , 2016, Revista brasileira de reumatologia.
[58] A. Gabrielli,et al. Cardiac involvement in polymyositis and dermatomyositis. , 2016, Autoimmunity reviews.
[59] I. Sjaastad,et al. In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset. , 2015, Rheumatology.
[60] Hyon K. Choi,et al. Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. , 2015, Rheumatology.
[61] Hyon K. Choi,et al. Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study , 2014, Annals of the rheumatic diseases.
[62] S. Kay,et al. Traditional Cardiovascular Risk Factors and Coronary Artery Calcification in Adults With Polymyositis and Dermatomyositis: A Danish Multicenter Study , 2015, Arthritis care & research.
[63] C. Kao,et al. Increased subsequent risk of acute coronary syndrome for patients with dermatomyositis/polymyositis: a nationwide population-based retrospective cohort study , 2015, Scandinavian journal of rheumatology.
[64] W. Rottbauer,et al. Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography , 2015, Journal of Neurology.
[65] J. Pope,et al. A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases , 2014, Arthritis Research & Therapy.
[66] F. Sung,et al. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study. , 2014, Thrombosis research.
[67] P. Suksaranjit,et al. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. , 2014, Seminars in arthritis and rheumatism.
[68] A. Sanguankeo,et al. Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis , 2014, Rheumatology International.
[69] Hanxion Liu,et al. Left Ventricular Diastolic Dysfunction in Patients with Dermatomyositis Without Clinically Evident Cardiovascular Disease , 2014, The Journal of Rheumatology.
[70] Han Wang,et al. Altered Lipid Levels in Untreated Patients with Early Polymyositis , 2014, PloS one.
[71] I. Sjaastad,et al. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity , 2013, Annals of the rheumatic diseases.
[72] P. Stein,et al. Heart rate variability in risk stratification of cardiac patients. , 2013, Progress in cardiovascular diseases.
[73] S. Shinjo,et al. Analysis of Metabolic Syndrome in Adult Dermatomyositis With a Focus on Cardiovascular Disease , 2013, Arthritis care & research.
[74] Hsiu-Hsi Chen,et al. Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population‐based longitudinal follow‐up study , 2013, The British journal of dermatology.
[75] E. Linos,et al. Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey , 2013, Arthritis Research & Therapy.
[76] M. Neovius,et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. , 2012, JAMA.
[77] F. Maldonado,et al. Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study , 2012, Respirology.
[78] I. Marie. Morbidity and Mortality in Adult Polymyositis and Dermatomyositis , 2012, Current Rheumatology Reports.
[79] R. Woodman,et al. Mortality and its predominant causes in a large cohort of patients with biopsy‐determined inflammatory myositis , 2012, Internal medicine journal.
[80] G. Kitas,et al. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors , 2011, Rheumatology International.
[81] I. Targoff,et al. Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. , 2011, International journal of cardiology.
[82] Sreeram V Ramagopalan,et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study , 2011, BMC medicine.
[83] I. Sjaastad,et al. Cardiac dysfunction in juvenile dermatomyositis: a case-control study , 2011, Annals of the rheumatic diseases.
[84] J. Case,et al. Serum Cardiac Troponin T, But Not Troponin I, Is Elevated in Idiopathic Inflammatory Myopathies , 2009, The Journal of Rheumatology.
[85] K. Rother,et al. Metabolic abnormalities and cardiovascular risk factors in children with myositis. , 2009, The Journal of pediatrics.
[86] Jeroen J. Bax,et al. The heart in sporadic inclusion body myositis: a study in 51 patients , 2009, Journal of Neurology.
[87] C. Pineau,et al. Arterial Events in Persons with Dermatomyositis and Polymyositis , 2009, The Journal of Rheumatology.
[88] I. Lundberg. The heart in dermatomyositis and polymyositis. , 2006, Rheumatology.
[89] G. Borgulya,et al. Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features: A Longitudinal Study of 162 Cases , 2004, Medicine.
[90] G. Hughes,et al. Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients , 2003, Medicine.
[91] F. Apple,et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle. , 1997, Clinical chemistry.
[92] G. Hutchins,et al. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. , 1982, The American journal of cardiology.